Rafat Zahra, Sasani Elahe, Salimi Yahya, Hajimohammadi Samaneh, Shenagari Mohammad, Roostaei Davoud
Department of Medical Microbiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Department of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Front Pediatr. 2021 Dec 24;9:805527. doi: 10.3389/fped.2021.805527. eCollection 2021.
In HIV-infected pediatrics, oral candidiasis (OC) is a global issue of concern due to its association with dysphagia, malnutrition, and mortality. The present systematic review and meta-analysis are the first to determine the prevalence of OC in HIV-infected pediatrics worldwide. We searched international (PubMed, Web of Science, Scopus, and Embase) databases for studies published between January 2000 to May 2020 reporting the epidemiologic features of OC in HIV-infected pediatrics. Inclusion and exclusion criteria were defined to select eligible studies. Data were extracted and presented according to PRISMA guidelines. The results of the meta-analysis were visualized as a forest plot. Heterogeneity was also analyzed using the , and τ statistics. The publication bias was evaluated using Egger test. The literature search revealed 1926 studies, of which 34 studies met the eligibility criteria, consisting of 4,474 HIV-infected pediatrics from 12 different countries. The overall prevalence of OC among HIV-infected pediatrics was 23.9% (95% CI 17.3-32.0%), and was the most prevalent etiologic agent. Pseudomembranous candidiasis was the predominant clinical manifestation in HIV-infected pediatrics suffering from OC. Thirty articles involving 4,051 individuals provided data on HIV treatment status. Among the 4,051 individuals, 468 (11.53%) did not receive HIV treatment. The data from 11 articles demonstrated that HIV treatment was significantly associated with a reduction in oral colonization or infection. In contrast, others showed the opposite relationship or did not report any statistical data. A high level of ( = 96%, < 0.01) and τ (τ = 1.36, < 0.01) was obtained among studies, which provides evidence of notable heterogeneity between studies. OC is approximately frequent in HIV-positive children. Therefore, efforts should be made to teach dental and non-dental clinicians who care for HIV-infected pediatrics to diagnose and treat this infection.
在感染艾滋病毒的儿科患者中,口腔念珠菌病(OC)是一个全球关注的问题,因为它与吞咽困难、营养不良和死亡率相关。本系统评价和荟萃分析首次确定了全球感染艾滋病毒的儿科患者中OC的患病率。我们在国际(PubMed、科学网、Scopus和Embase)数据库中搜索了2000年1月至2020年5月期间发表的报告感染艾滋病毒的儿科患者中OC流行病学特征的研究。定义了纳入和排除标准以选择符合条件的研究。数据根据PRISMA指南进行提取和呈现。荟萃分析的结果以森林图的形式可视化。还使用 和τ统计量分析了异质性。使用Egger检验评估发表偏倚。文献检索共发现1926项研究,其中34项研究符合纳入标准,涉及来自12个不同国家的4474名感染艾滋病毒的儿科患者。感染艾滋病毒的儿科患者中OC的总体患病率为23.9%(95%CI 17.3 - 32.0%),并且 是最常见的病原体。假膜性念珠菌病是感染艾滋病毒且患有OC的儿科患者的主要临床表现。30篇涉及4051名个体的文章提供了关于艾滋病毒治疗状况的数据。在这4051名个体中,468名(11.53%)未接受艾滋病毒治疗。11篇文章的数据表明,艾滋病毒治疗与口腔 定植或感染的减少显著相关。相比之下,其他研究显示了相反的关系或未报告任何统计数据。研究之间获得了高水平的 ( = 96%, < 0.01)和τ(τ = 1.36, < 0.01),这为研究之间存在显著异质性提供了证据。OC在艾滋病毒阳性儿童中较为常见。因此,应努力培训照顾感染艾滋病毒儿科患者的牙科和非牙科临床医生,以便诊断和治疗这种感染。